Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.275 AUD | 0.00% | +10.00% | +14.58% |
Mar. 15 | Nova Eye Medical Completes Retail Entitlement Offer | MT |
Feb. 22 | Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 301
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Glaucoma Surgical Devices
97.9
%
| 13 | 98.2 % | 17 | 97.9 % | +26.82% |
AlphaRET
2.1
%
| 0 | 1.8 % | 0 | 2.1 % | +51.04% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
57.8
%
| 9 | 65.6 % | 10 | 57.8 % | +12.04% |
Europe
24.1
%
| 4 | 26.9 % | 4 | 24.1 % | +14.30% |
Asia Pacific
16.0
%
| 1 | 5.5 % | 3 | 16.0 % | +269.84% |
Other
1.6
%
| 0 | 1.4 % | 0 | 1.6 % | +42.71% |
Australia
0.5
%
| 0 | 0.6 % | 0 | 0.5 % | +10.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Spurling
CEO | Chief Executive Officer | - | 11-03-30 |
David Lubeck
CTO | Chief Tech/Sci/R&D Officer | - | 18-10-17 |
Mark Flynn
IRC | Investor Relations Contact | - | - |
Kate Hunt
PRN | Corporate Officer/Principal | - | - |
Simon Gray
SEC | Corporate Secretary | - | 20-06-23 |
Joaquin V. Wolff
PRN | Corporate Officer/Principal | 66 | 18-07-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Victor Previn
FOU | Founder | 65 | 84-12-31 |
Thomas Spurling
CEO | Chief Executive Officer | - | 11-03-30 |
Rahmon Coupe
BRD | Director/Board Member | 60 | 13-05-14 |
Dan Webb
BRD | Director/Board Member | - | - |
Mike Southard
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 214,471,005 | 191,713,370 ( 89.39 %) | 0 | 89.39 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.58% | 41.03M | |
+8.40% | 219B | |
+6.33% | 183B | |
+10.70% | 133B | |
+24.94% | 108B | |
+0.27% | 63.06B | |
+12.07% | 52.02B | |
+3.96% | 48.2B | |
-0.15% | 40.37B | |
+14.67% | 39.35B |
- Stock Market
- Equities
- EYE Stock
- Company Nova Eye Medical Limited